MedTrace Logo

Age and Refraction in Predicting Myopia Progression in COVID-19

NCT05305274 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34400

Last updated 2022-03-31

No results posted yet for this study

Summary

To determine the longitudinal changes of age and refraction in predicting myopia progression with risk under the coronavirus disease 2019 (COVID-19) pandemic in a 3-year follow-up of a Chinese cohort.

Conditions

  • Refraction Error
  • Myopia

Interventions

OTHER

screening

This study included 34,400 students, as part of the Tianjin Eye Study who performed a 3-year follow-up from 2019 to 2021. All participants underwent yearly noncycloplegic refraction and ocular examinations. Time-related changes in sphere, cylinder, and spherical equivalent (SE) measurements in both sexes were analyzed.

Sponsors & Collaborators

  • Tianjin Eye Hospital

    lead OTHER

Principal Investigators

  • Yan Wang, director · Tianjin Eye Hospital

Eligibility

Min Age
6 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2021-10-31
Completion
2021-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05305274 on ClinicalTrials.gov